Pharma Tidbits

Friday: Fact Check Friday
(Topic: Pore Myths)

🔍Fact Check Friday: The Truth About Pores 🔍
Myth:"You can open and close your pores." Fact: Pores are not muscles; they don't open or close. However, they can appear larger when clogged with oil, dirt, and dead skin cells.

👉 The Tip: To make pores look smaller, keep them clean. Consistent use of a gentle cleanser, niacinamide, and salicylic acid (a BHA) can help dissolve clogs and improve their appearance.

💊 Drug of the Day: AMIODARONE

1. Description (Pharmacological Class):
Amiodarone is a Class III antiarrhythmic agent.It is a benzofuran derivative with a complex pharmacological profile, possessing characteristics of all four Vaughan-Williams antiarrhythmic classes.

2. Mechanism of Action:
Its primary effect is blockade of potassium channels,prolonging the action potential duration and refractory period (Class III effect). However, it also has:

· Sodium channel blockade (Class I effect).
· Non-competitive beta-adrenergic blockade (Class II effect).
· Calcium channel blockade (Class IV effect).
This multi-channel blockade makes it a very potent and broad-spectrum antiarrhythmic.

3. Indications:
· Treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia (when other agents are ineffective or contraindicated).
· Management of supraventricular tachyarrhythmias (e.g., atrial fibrillation, flutter) to maintain sinus rhythm.

4. Contraindications:
· Severe sinus-node dysfunction, causing marked bradycardia or 2nd/3rd-degree heart block (unless a functioning pacemaker is in place).
· Known hypersensitivity to amiodarone or any component (including iodine).
· Cardiogenic shock.
· Pregnancy and breastfeeding.

5. Safety in Pregnancy:
· FDA Pregnancy Category D. Amiodarone and its metabolite cross the placenta and can cause fetal harm, including hypothyroidism, hyperthyroidism, bradycardia, neurodevelopmental abnormalities, and premature birth. It is contraindicated and should be used only if the mother's life is in danger from a life-threatening arrhythmia that does not respond to other agents.

6. Available Dosage Forms:
· Oral tablets (100 mg, 200 mg, 400 mg).
· Solution for Intravenous (IV) infusion.

7. Common Side Effects:
· Pulmonary: Pulmonary toxicity (fibrosis, pneumonitis) – can be fatal. (Baseline and periodic chest X-rays are required).
· Hepatic: Elevated liver enzymes, hepatitis, cirrhosis.
· Thyroid: Both hypothyroidism and hyperthyroidism.
· Ocular: Corneal microdeposits (usually reversible), optic neuritis/neuropathy (can lead to blindness).
· Dermatological: Photosensitivity, blue-gray skin discoloration.
· Cardiac: Bradycardia, heart block.
· Neurological: Peripheral neuropathy, tremor, ataxia.
· Drug Interactions: Amiodarone is a potent inhibitor of CYP3A4 and CYP2C9 and can increase levels of many drugs (e.g., warfarin, digoxin, statins), necessitating dose adjustments and close monitoring.

💊 Drug of the Day: IBUPROFEN

1. Description (Pharmacological Class): Ibuprofen is a non-steroidal anti-inflammatory drug(NSAID). It is a propionic acid derivative and a non-selective cyclooxygenase (COX) inhibitor.

2. Mechanism of Action: It exerts its effects by inhibiting the enzymes cyclooxygenase-1(COX-1) and cyclooxygenase-2 (COX-2). This inhibition blocks the conversion of arachidonic acid to prostaglandins, which are key mediators of pain, inflammation, and fever.

3. Indications:
· Relief of mild to moderate pain (e.g., headache, dental pain, dysmenorrhea).
· Reduction of inflammation associated with conditions like osteoarthritis and rheumatoid arthritis.
· Reduction of fever.

4. Contraindications:
· Hypersensitivity (e.g., asthma, urticaria, allergic-type reactions) to ibuprofen, aspirin, or other NSAIDs.
· History of asthma or bronchospasm induced by NSAIDs.
· Active peptic ulcer disease or gastrointestinal bleeding.
· Third trimester of pregnancy.
· Severe hepatic, renal, or cardiac failure.

5. Safety in Pregnancy:
· Avoid use, especially during the third trimester.
· FDA Pregnancy Category C (first and second trimesters) and D (third trimester). Use of NSAIDs in late pregnancy can cause premature closure of the fetal ductus arteriosus and may inhibit labor.

6. Available Dosage Forms:
· Oral tablets (200 mg [OTC], 400 mg, 600 mg, 800 mg).
· Chewable tablets (50 mg, 100 mg).
· Oral suspension / Liquid (100 mg/5 mL).
· Topical gel / cream (5%, 10%).

7. Common Side Effects:
· Gastrointestinal: Dyspepsia (indigestion), nausea, abdominal pain, GI ulceration, bleeding, perforation.
· Central Nervous System: Headache, dizziness.
· Cardiovascular: Fluid retention, edema, hypertension, increased risk of serious cardiovascular thrombotic events (MI, stroke).
· Renal: Rare risk of renal impairment, especially in dehydrated patients or those with pre-existing kidney disease.